STOCK TITAN

Corbus Pharmaceuticals Holdings (CRBP) Free Cash Flow by Year

CRBP NASDAQ

Corbus Pharmaceuticals Holdings, Inc. recorded an outflow of $64.5M in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Corbus Pharmaceuticals Holdings, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow -$64.5M
YoY n/m
5Y CAGR n/m
10Y CAGR n/m
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CRBP Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Free Cash Flow-$64.5Mn/m-$41.8Mn/m-$36.1Mn/m-$37.6Mn/m-$48.2Mn/m-$100.2Mn/m-$48.5Mn/m-$32.4Mn/m-$28.5Mn/m-$13.9Mn/m-$4.7Mn/m-$2.4MN/A

CRBP Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Free Cash Flow-$29.6Mn/m-$25.6Mn/mN/AN/A-$16.6M-$16.4MN/AN/AN/AN/A-$6.0Mn/m-$7.2Mn/m

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Corbus Pharmaceuticals Holdings, Inc. financials

Frequently Asked Questions

What was Corbus Pharmaceuticals Holdings, Inc.'s free cash flow in fiscal year 2025?

Corbus Pharmaceuticals Holdings, Inc. recorded an outflow of $64.5M in free cash flow in fiscal year 2025.

How fast is Corbus Pharmaceuticals Holdings, Inc.'s free cash flow growing?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported an outflow of $41.8M in free cash flow in fiscal year 2024 and an outflow of $64.5M in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

What was Corbus Pharmaceuticals Holdings, Inc.'s free cash flow in the most recent quarter?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported -$29.6M in free cash flow in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported on that line in every period on record.